Introduction
============

Thyroid cancer (TC) is the most well-known type of endocrine-related malignancy; TC has become threefold more common in the past 30 years ([@B2]; [@B17]; [@B16]). Fine-needle aspiration (FNA) plays a critical role in differentiating thyroid nodules because of its high sensitivity and specificity ([@B14]). However, it is invasive and involves high non-diagnostic (10--15%) or indeterminate (10--20%) outcomes ([@B15]).

Ultrasound elastography is a non-invasive tool, first introduced by [@B12], which has shown promise for the evaluation of tissue stiffness, providing additional and clinically relevant information. Mapping the stiffness can either be estimated by analyzing the strain in tissue under stress (quasi-static method) or by imaging of shear waves, mechanical waves, whose propagation is governed by tissue stiffness rather than by its bulk modulus ([@B6]). Most malignant nodules are portrayed by the organization of their unusually firm stroma because of the features of collagen and myofibroblasts, which enable the identification of thyroid cancers with elastography imaging ([@B10]).

Nowadays, Sound Touch Elastography (STE) has emerged as a novel elastography technique, which can both provide maps of the strain and of the shear waves. STE allows for quantification of tissue stiffness with the elastic ratio (EI) and shear modulus (G) using the same ultrasound equipment. The main aim of our study was to evaluate the usefulness of STE in predicting malignant thyroid nodules using histopathological analysis as the reference standard.

Materials and Methods {#s1}
=====================

Study Population
----------------

This study was approved by the Ethics Committee of the Shenzhen people's Hospital. Between June 2016 and December 2017, 95 patients referred for ultrasound examinations were recruited for this study. All participants signed the informed consent form required by the human study committee before enrollment. Nine participants were lost to follow up. The inclusion criteria were as follows. (1) The nodules were stable when detected by ultrasound (US), (2) the size of the nodules ranged from 0.5 to 3.0 cm, (3) the nodules appeared solid or almost solid (\<20% cystic) on US, (4) sufficient thyroid tissue surrounded the nodules at the same depth and US cross-section, (5) no intervention or surgery on the nodules had been performed before the US examination, and (6) thyroid surgery or fine needle aspiration biopsy (FNAB) was performed after the US examination within 1 week. Not every nodule could be included for the patients with multiple nodules in this study because of the size and component of nodule restrictions. For patients who had multiple nodules, only the nodule that best satisfied the inclusion criteria was included. Finally, 86 patients (mean age 46.43 ± 12.17 years, range 26--78 years) with 86 nodules (mean size 1.60 ± 0. 39 cm, range 1.01--2.98 cm) met the inclusion criteria and were enrolled in this study, including 24 thyroid papillary carcinomas (TPC) and 62 benign nodules. Thirty-eight patients underwent FNAB and 28 underwent surgery in our hospital.

Imaging Techniques
------------------

Both conventional US and STE examinations were performed with a Resona 7 ultrasound system (Mindray Medical Solutions, ıShenzhen, China) equipped with a 11L3 linear array transducer (bandwidth frequency of 3--11 MHz) and STE software. When the patients met the inclusion criteria, an informed consent was obtained. Patients were in a supine position with a fully exposed neck. Following which, an STE examination of the lesion was performed. First, the examination probe was kept in contact with the skin. Next, the ROI size was adjusted, such that both the lesion and enough surrounding tissues were included in the ROI and the majority of the lesion's longitudinal section was included in the center of the ROI. When the left of the dual images was nearly green (area \>95%) of ROI, the elastographic image of the lesion was acquired and saved. The nodule's morphology characteristics, size, boundary, echoes, and color Doppler features were observed by conventional US and stored. First, switching to EI of the STE model, the probe touched the skin lightly, adjusting the size of the region of interest (ROI), ensured that the nodule and sufficient surrounding gland tissue were included in the ROI. The maximum longitudinal section of the nodules was displayed at the center of the screen, and then the patients were instructed to hold their breath, when the green control bar at the bottom of the screen was stable, pressed the update button and the image was saved; then, the same method was used to obtain the short axis section. Second, switching to the shear wave model, the patient maintained the same position without breathing, when the left of the dual images is nearly green (area \>95%) of the ROI, the update button was pressed to obtain the long and short axis section images.

Elastography images were produced, the nodules were circled, and the EI and G data (including *G*~max~, *G*~min~, *G*~mean~, and *G*~sd~) were obtained. The average of the long-axis and short-axis values were used for further statistical analysis.

All the examinations were conducted by a sonographer with more than 7 years of experience in US and 3 years of experience in elastography and who was blind to the histopathological results.

Pathological Diagnoses
----------------------

All nodules were confirmed by histology in this study. All pathological diagnoses were performed by a pathologist with more than 8 years of experience in thyroid pathological examination.

Statistical Analysis
--------------------

The STE data were recorded, including EI, *G*~max~, *G*~min~, *G*~mean~, and *G*~sd~. The true-positive (TP), true-negative (TN), false-positive (FP), and false-negative (FN) numbers per method were calculated. The Kruskal--Wallis non-parametric test was used to compare whether there were significant differences in the EI, *G*~max~, *G*~min~, *G*~mean~, and *G*~sd~ between benign and malignant nodules. The abilities of EI, *G*~max~, *G*~min~, *G*~mean~, and *G*~sd~ to differentiate malignant from benign nodules were evaluated by receiver-operating characteristic (ROC) curve analysis. The best cutoff values were obtained using the Youden index (sensitivity+specificity-1) from the ROC curve analysis. The sensitivity (Sen), specificity (Spe), positive likelihood ratio (LR+), and negative likelihood ratio (LR-) were calculated using the chi-squared test (χ^2^-test). A *P*-value \< 0.05 was considered to be statistically significant. The values were then combined to obtain an overall STE analysis. The area under the summary ROC (SROC) curve was used. The pooled Sen, Spe, LR+, and LR- were calculated. These data were analyzed with Stata 14.0 for Mac (Stata Corp, College Station, TX, United States) and GraphPad Prism 6.0 for Mac (GraphPad Software, Inc., San Diego, CA, United States).

Results
=======

Histology
---------

The pathology results revealed that among the nodules (Figures [1A--C,G,H](#F1){ref-type="fig"}), there were 24/86 (27.90%) malignant papillary carcinomas and 62/86 (72.10%) benign nodules (46 goiter nodules and 16 adenomas) (Figures [2A--C,H](#F2){ref-type="fig"}).

![Images showing a thyroid papillary carcinoma in a 48-year-old man. **(A--C)** The B- and color-mode images show a hypoechoic nodule by ultrasound, visible blood flow signal around; **(D,E)** short and long axis of the nodule evaluated by EI (the strain ratio both are 0.11%); **(F)** quantitative shear wave values (*G*~mean~: 12.09 kPa, *G*~max~: 27.12 kPa, *G*~sd~: 4.95 kPa) were measured by drawing a ROI around the nodule to encompass the maximum area but not include the tissue outside the nodule displayed on the B-mode image; **(G,H)** the pathology results confirmed that the nodule was a thyroid papillary carcinoma.](fphar-09-01359-g001){#F1}

![Images showing a nodular goiter in a 46-year-old woman. **(A--C)** The B- and color-mode images show a hypoechoic nodule by ultrasound, minor visible blood flow signal around and inside; **(D,E)** short and long axis of the nodule evaluated by the EI (the strain ratios are 0.27 and 0.39%, respectively); **(F,G)** quantitative shear wave values (*G*~mean~: 4.24 kPa, *G*~max~: 10.30 kPa, *G*~sd~: 1.68 kPa in the short axis; *G*~mean~: 4.39 kPa, *G*~max~: 8.03 kPa, *G*~sd~: 1.32 kPa in the long axis) were measured by drawing a ROI around the nodule to encompass the maximum area but not include the tissue outside the nodule displayed on the B-mode image; **(H)** the pathology results confirmed that the nodule was a nodular goiter.](fphar-09-01359-g002){#F2}

EI of Benign and Malignant Nodules
----------------------------------

The nodules' stiffness was indicated by different color changes. As shown in Figures [1D,E](#F1){ref-type="fig"} and Figures [2D,E](#F2){ref-type="fig"}, blue in the upper left indicates the softest and red indicates the hardest. In this study, 24 malignant nodules were red (20 nodules were bright red, which occupied the entire nodule, and the other 4 cases of red area more than 80%), and 62 benign nodules had similar color: green or yellow and white.

The EI measurements of benign and malignant nodules are shown in Table [1](#T1){ref-type="table"}. The mean EI of malignant nodules was statistically lower than that of benign nodules (0.19 ± 0.02% vs. 0.29 ± 0.01%, *P* \< 0.001). The area under the ROC curve (AUROC) for the EI of thyroid nodules for the diagnosis of malignant nodules was 0.8. The cutoff value of the EI for malignant nodules was 0.215%. Using this cut-off value, the TP, FP, FN, and TN were 17, 17, 7, and 45, respectively. The Sen, Spe, LR+, and LR- of the EI for diagnosing malignant nodules were 71%, 73%, 2.58, and 0.40, respectively (Figure [3](#F3){ref-type="fig"} and Table [1](#T1){ref-type="table"}).

![The ROC of the EI (cutoff: 0.215%, Sen 71%, Spe 73%), *G*~max~ (cutoff: 15.82 kPa, Sen 79%, Spe 79%), *G*~mean~ (cutoff: 6.715 kPa, Sen 86%, Spe 68%), and *G*~sd~ (cutoff: 2.00 kPa, Sen 78%, Spe 64%).](fphar-09-01359-g003){#F3}

###### 

The EI and G measurements of benign and malignant nodules.

  Lesion      MAX         MIN     Mean ± SD   *P*            Cut-off   AUROC    SEN    SPE    LR+    LR-    TP     FP   FN   TN   
  ----------- ----------- ------- ----------- -------------- --------- -------- ------ ------ ------ ------ ------ ---- ---- ---- ----
  EI          Benign      0.78    0.13        0.29 ± 0.01    0.0001    0.215%   0.78   0.71   0.73   2.58   0.40   17   17   7    45
              Malignant   0.34    0.07        0.19 ± 0.02                                                                         
  *G*~mean~   Benign      0.51    0.13        5.82 ± 0.30    0.0006    6.715    0.78   0.86   0.68   2.71   0.19   21   20   3    42
              Malignant   0.34    0.07        8.22 ± 0.78                                                                         
  *G*~max~    Benign      49.36   4.48        12.12 ± 0.99   0.0001    15.82    0.84   0.79   0.79   3.78   0.26   19   13   5    49
              Malignant   41.97   8.03        21.62 ± 1.65                                                                        
  *G*~min~    Benign      5.61    0.14        2.64 ± 0.17    0.5905    --       --     --     --     --     --     --   --   --   --
              Malignant   8.48    0.45        2.83 ± 0.37                                                                         
  *G*~sd~     Benign      0.51    0.13        1.75 ± 0.15    0.0002    2.00     0.74   0.78   0.64   2.21   0.34   19   22   5    40
              Malignant   0.34    0.07        2.92 ± 0.30                                                                         
                                                                                                                                  

SEN, sensitivity; SPE, specificity; LR+, positive likelihood ratio; LR-, negative likelihood ratio; TP, true-positive; TN, true-negative; FP, false-positive; FN, false-negative.

G of Benign and Malignant Nodules
---------------------------------

The nodules' stiffness was indicated by different color changes like EI. As shown in Figures [1F,G](#F1){ref-type="fig"}, [2F,G](#F2){ref-type="fig"}, blue in the upper left indicates the softest and red indicates the hardest. In this study, all 24 malignant nodules showed a reddish periphery (red rim-like) and a yellow or yellow-green in the middle, while the color of 62 benign nodules was similar to that of the surrounding tissues and was either green or yellow and had no red nodules with malignant nodules.

The G measurements of benign and malignant nodules are shown in Table [1](#T1){ref-type="table"}. *G*~max~, *G*~mean~, and *G*~sd~ were significantly higher in malignant nodules than in benign nodules (*P* \< 0.005) (Table [1](#T1){ref-type="table"}). There were no significant differences in *G*~min~ (*P* = 0.59). The ROC curves of the three G parameters are shown in Figure [3](#F3){ref-type="fig"}. The optimal cut-off values with respective AUC are presented in Table [1](#T1){ref-type="table"}. Compared with other G parameters, *G*~max~ with the optimal cutoff value set at 15.82 kPa had the highest AUC value, the AUROC was 0.840 (95% CI: 0.759--0.928). Using this cutoff point, showing diagnostic Sen, Spe, LR+, and LR- were 79.17%, 79.03%, 3.776, and 0.261, respectively (Table [1](#T1){ref-type="table"}). The other two G parameters, *G*~mean~ and *G*~sd~, with the same cutoff value were 6.715 and 2.00 kPa, respectively. The details are shown in Table [1](#T1){ref-type="table"} and Figure [3](#F3){ref-type="fig"}.

Pooled EI and G of Benign and Malignant Nodules
-----------------------------------------------

We pooled the EI, *G*~max~, *G*~mean~, and *G*~sd~ using the Midas module in Stata 14.0, which is equipped with the bivariate mixed-effects regression model developed by [@B20], [@B19]), modified for the synthesis of diagnostic test data, to pool the statistical indexes and draw the statistical graphs. The pooled sensitivity (P-Sen) and specificity (P-Spe), pooled positive likelihood ratio (PLR+), negative likelihood ratio (PLR-), diagnostic odds ratio (DOR), OR with corresponding 95% confidence intervals (CI), and area under the SROC curve were used to examine the diagnostic accuracy. As shown in Figure [4](#F4){ref-type="fig"}, significant heterogeneity in P-Sen (*I*^2^ = 0%, *Q* = 2.02) and P-Spe (*I*^2^ = 16.69%, *Q* = 3.60) were detected. The P-Sen, P-Spe, PLR+, PLR-, DOR, OR, and area under the SROC curve were 79% (95% CI: 70--86%), 71% (95% CI: 65--76%), 2.73 (95% CI: 2.19--3.40), 0.29 (95% CI: 0.20--0.44), 2.23 (95% CI: 1.67--2.79), 9.29 (95% CI: 5.29--16.32), and 82% (95% CI: 78--85%), respectively (Figures [4](#F4){ref-type="fig"}, [5](#F5){ref-type="fig"}).

![The pooled Sen **(A)**, Spe **(B)**, LR+**(C)**, LR-**(D)**, DOR **(E)**, and OR **(F)** of the EI, *G*~max~, *G*~mean~, and *G*~sd~ with 95% CI.](fphar-09-01359-g004){#F4}

![The SROC of the EI, *G*~max~, *G*~mean~, and *G*~sd~ with 95% CI.](fphar-09-01359-g005){#F5}

Discussion
==========

Approximately 60,000 people a year will be diagnosed with thyroid cancer in the United States. Statistics show that more women than men are diagnosed with thyroid cancer. It is the fourth most common type of cancer among women ([@B11]). Tumor stiffness can reflect the nature of tumors to a certain extent ([@B9]). The harder the tissue, the higher the risk of malignancy ([@B13]). Overall, cancerous thyroid tumors tend to be harder than benign ones. Nodule stiffness is normally determined by palpation by a physician, but smaller nodules, particularly those that are deeply located, cannot be palpated.

Elastography is a non-invasive ultrasound method for assessing the mechanical qualities of the tissues, for example, elasticity and stiffness ([@B1]). Since the thyroid is a superficial organ, it can undoubtedly be assessed by all elastography techniques. Elastography has been generally acknowledged and utilized for distinguishing the stiffness of thyroid nodules ([@B5]). Different techniques, based on real-time two-dimensional image sequencing after applying a force that is either dynamic or slowly varying (and considered "quasi-static"), were developed. The principle of elastography is based on US measurement of tissue displacement ([@B6]). All elastographic techniques utilize signal processing to create an image and/or to evaluate the stiffness and elasticity of the investigated tissue ([@B7]). Two basic concepts are currently used for US elastography: to evaluate the strain or distortion of a tissue because of a power (static elastography, SE), the propagation speed of a shear wave (acoustic radiation force impulse imaging, ARFI), or the measurement of the Young's modulus of the tissue (shear wave elastography, SWE). Manufacturers have built their elastography modules utilizing any of these principles and their own particular innovations.

All shear wave data in the entire ROI could be received at one time to achieve real time two-dimensional SWE imaging. STE can obtain the quantitative elastic parameters, EI and G, and non-invasively evaluate tissue stiffness. In this study, the diagnostic and clinical values of the EI and G of benign and malignant thyroid nodules were compared. The cut-off points of the EI, *G*~max~, *G*~mean~, and *G*~sd~ were 0.215% (Sen: 71%, Spe: 73%), 15.82 kPa (Sen: 79%, Spe: 79%), 6.715 kPa (Sen: 86%, Spe: 68%), and 2.00 kPa (Sen: 78%, Spe: 64%), respectively. A meta-analysis reported the diagnostic value of elastography in predicting malignant thyroid nodules. [@B18] reported results indicating that real-time elastography (RTE) was more accurate than SWE as suggested by higher Sen, Spe, and AUROC. The P-Sen, P-Spe, and SROC of RTE and SWE were: 82.9% (95% CI: 79.9--85.5%), 82.8% (95% CI: 78.9--86.2%), and 88.9% and 78.4% (95% CI: 73.2--82.8%), 82.4% (95% CI: 76.6--87.1%), and 85.9%, respectively. We also performed a meta-analysis on ARFI for differentiating thyroid nodules ([@B4]). A total of 13 cohort studies involving 1617 thyroid nodules from 1451 patients were identified. Of 13 studies, one was retrospective and the others were prospective. The pooled Sen, Spe, LR+, LR-, and DOR of SWE in differentiating malignant from benign thyroid nodules were 86.3% (95% CI: 78.2--91.7), 89.5% (95% CI: 83.3--93.6), 7.04 (95% CI: 4.40--11.26), 0.17 (95% CI: 0.10--0.31), and 46.66 (95% CI: 19.47--111.81), respectively. The area under the SROC curve was 94% (95% CI: 92--96). In this study, we also pooled the data by systematic review and obtained P-Sen, P-Spe, and area under the SROC curve at 79% (95% CI: 70--86%), 71% (95% CI: 65--76%), and 82% (95% CI: 78--85%), respectively.

Regarding why on the STE elasticity image, the malignant nodules of EI showed a red nodule, the SWE images showed a red rim-like, and the inside were the same color as the benign nodules. We believe that this is attributable to the different principles of the two imaging methods. The EI is a stain-force imaging system. After an external force to the tissue which would cause deformation. Unlike other elastography modalities, STE does not need to be pressurized by the probe, which could monitor the third party's pulsating blood vessels and breathing. Regarding the nodule stiffness, for example, of shelled raw eggs (Figures [6A,B](#F6){ref-type="fig"}), when a force is applied, it will cause a slight deformation, but internal deformation would not be detected, and therefore, the machine would interpret that the nodules are all hard, in EI with pure red. In shear wave imaging, the probe emits shear waves into the nodule that are received by the probe, and can detect in-depth the hardness of different components inside the nodule and display, similar to detecting a peeled cooked egg (Figures [6C,D](#F6){ref-type="fig"}), which could display various internal. The details of stiffness were shown in different colors. During the invasive growth of malignant tumors, internal necrosis is often accompanied by shear wave elasticity. This is termed the "stiff-rim" sign, consistent with the relevant reports ([@B21]). An increase in the stiffness of the surrounding tissue may signify that cancer cells have invaded the surrounding tissue of the tumor ([@B8]). Studies have shown that tumor tissue infiltration around the tumor is an independent prognostic factor of tumor recurrence and patient death ([@B3]).

![Simple schematic diagram of EI **(A,B)** and shear wave imaging **(C,D)**, **(A,B)** show the shelled raw eggs, when a force is applied, it will cause a slight deformation, but internal deformation would not be detected, and therefore, the machine would interpret that the nodules are all hard, in EI with pure red. **(C,D)** Show in shear wave imaging, the probe emits shear waves into the nodule that are received by the probe, and can detect in-depth the hardness of different components inside the nodule and display, similar to detecting a peeled cooked egg which could display various internal.](fphar-09-01359-g006){#F6}

These results suggested that tissue stiffness detected by STE can excellently reflect the nature of the nodules. Moreover, STE has some advantages. First, the EI and G can be obtained with the same ultrasound equipment with the same probe; second, the elastography images can be stored in the equipment and analyzed later, which reduces the examination time and the patient's discomfort. However, the study still had limitations. First, the number of cases was small, further study is needed with a larger sample size. Second, only the EI and G were evaluated by ROC curve analysis in this study, and in the further research, E and V and edge infiltration should be also evaluated.

Conclusion
==========

The present study showed comparable results for the novel quantitative STE for the differentiation of thyroid nodules. With high Sen and Spe, STE could be recognized as a new ultrasound diagnostic method in evaluating benign and malignant thyroid nodules. However, the sample of this preliminary study may not be representative of a screening population. Multicenter prospective studies with non-surgical populations and larger samples and more noteworthy difference of pathology are warranted.
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